Abstract
A 25-year-old man with hepatocellular carcinoma developed severe muscular weakness and pain 15 days after transcatheter arterial chemoembolization (TACE). The diagnosis of rhabdomyolysis was made based on myalgia localized in the bilateral upper extremities (bilateral trapezius, deltoid, biceps brachii, and teres major muscles) on magnetic resonance imaging and increased levels of muscle-derived serum enzymes. In this case, some drugs administered during the clinical course of TACE (diclofenac, famotidine, and cefotiam dihydrochloride) were suspected to be involved in the rhabdomyolysis, but the exact cause of rhabdomyolysis was not identified. The symptoms were completely improved by right trisegmentectomy of the liver following conservative treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bolgiano EB (1994) Acute rhabdomyolysis due to body building exercise. Report of a case. J Sports Med Phys Fitness 34(1):76–78
Boyd JF (1987) Fatal rhabdomyolysis in marathon runner. Lancet 1(8541):1089
Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734–1739
Alba E, Valls C, Dominguez J et al (2008) Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. Am J Roentgenol 190(5):1341–1348
Hochster HS, Green MD, Speyer J et al (1985) 4′-Epidoxorubicin (Epirubicin): activity in hepatocellular carcinoma. J Clin Oncol 3(11):1535–1540
Yoshikawa M, Saisho H, Ebara M et al (1994) A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 33(Suppl 1):49–52
Burney IA (1998) Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J 91(5):467–470
Tajima T, Honda H, Kuroiwa T et al (2002) Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol 13(9 Pt 1):893–900
Rafiq I, Anderson DJ (2006) Acute rhabdomyolysis following acute compartment syndrome of upper arm. J Coll Phys Surg Pak 16(11):734–735
Sukegawa I, Miyabe M, Fujii T, Hoshi T, Takahashi S, Toyooka H (2003) Rhabdomyolysis after nephrectomy in the lateral flexed decubitus position. Masui 52(8):882–885
Delrio FG, Park Y, Herzlich B, Grob D (1996) Case report: diclofenac-induced rhabdomyolysis. Am J Med Sci 312(2):95–97
Brössner G, Engelhardt K, Beer R et al (2004) Accidental intrathecal infusion of cefotiam: clinical presentation and management. Eur J Clin Pharmacol 60(5):373–375
Schreiber DH, Anderson TR (2006) Statin-induced rhabdomyolysis. J Emerg Med 31(2):177–180
Japan Pharmaceutical Reference (2008) Drug safety information. Gaster Tablets 10 mg and 20 mg. Available at: http://www.e-search.ne.jp/~jpr/PDF/ASTELLAS42.PDF. Accessed 15 July 2008
Kakuda W, Naritomi H, Miyashita K, Kinugawa H (1999) Rhabdomyolysis lesions showing magnetic resonance contrast enhancement. J Neuroimaging 9(3):182–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matake, K., Tajima, T., Yoshimitsu, K. et al. Rhabdomyolysis Developing After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 32, 1284–1287 (2009). https://doi.org/10.1007/s00270-009-9670-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-009-9670-z